JP2024538646A5 - - Google Patents

Info

Publication number
JP2024538646A5
JP2024538646A5 JP2024519765A JP2024519765A JP2024538646A5 JP 2024538646 A5 JP2024538646 A5 JP 2024538646A5 JP 2024519765 A JP2024519765 A JP 2024519765A JP 2024519765 A JP2024519765 A JP 2024519765A JP 2024538646 A5 JP2024538646 A5 JP 2024538646A5
Authority
JP
Japan
Prior art keywords
seq
nucleotide sequence
strand comprises
nucleotides
antisense strand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024519765A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538646A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077447 external-priority patent/WO2023056478A1/en
Publication of JP2024538646A publication Critical patent/JP2024538646A/ja
Publication of JP2024538646A5 publication Critical patent/JP2024538646A5/ja
Pending legal-status Critical Current

Links

JP2024519765A 2021-10-01 2022-10-01 ＡＮＧＰＴＬ７を標的化するためのｉＲＮＡ組成物および方法 Pending JP2024538646A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163251203P 2021-10-01 2021-10-01
US63/251,203 2021-10-01
US202163287414P 2021-12-08 2021-12-08
US63/287,414 2021-12-08
PCT/US2022/077447 WO2023056478A1 (en) 2021-10-01 2022-10-01 iRNA COMPOSITIONS AND METHODS FOR TARGETING ANGPTL7

Publications (2)

Publication Number Publication Date
JP2024538646A JP2024538646A (ja) 2024-10-23
JP2024538646A5 true JP2024538646A5 (https=) 2025-12-05

Family

ID=85783703

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024519765A Pending JP2024538646A (ja) 2021-10-01 2022-10-01 ＡＮＧＰＴＬ７を標的化するためのｉＲＮＡ組成物および方法

Country Status (4)

Country Link
US (1) US20240409943A1 (https=)
EP (1) EP4408438A4 (https=)
JP (1) JP2024538646A (https=)
WO (1) WO2023056478A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004070062A2 (en) * 2003-02-04 2004-08-19 Wyeth Compositions and methods for diagnosing and treating cancers
EP2397559A1 (en) * 2010-06-17 2011-12-21 Max-Delbrück-Centrum Für Molekulare Medizin Stage-specific biomarkers for the diagnosis of acute kidney injury
MX2021008797A (es) * 2019-01-23 2022-01-31 Regeneron Pharma Tratamiento de afecciones oftalmicas con inhibidores de proteinas relacionadas a angiopoyetina 7 (angptl7).
JP2022535717A (ja) * 2019-05-24 2022-08-10 エンピリコ インク． アンジオポエチン様７（ａｎｇｐｔｌ７）関連疾患の処置
US11865134B2 (en) * 2021-02-26 2024-01-09 Regeneron Pharmaceuticals, Inc. Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors
WO2023031359A1 (en) * 2021-09-02 2023-03-09 Silence Therapeutics Gmbh Nucleic acids for inhibiting expression of complement factor b (cfb) in a cell

Similar Documents

Publication Publication Date Title
EP1141278B1 (en) Therapeutic pde4d phosphodiesterase inhibitors
JP5592892B2 (ja) 眼障害の治療方法
CA2210998C (en) Inhibition of neovascularization using vegf-specific oligonucleotides
RU2011124528A (ru) ОПОСРЕДОВАННОЕ PHKI ИНГИБИРОВАНИЕ Rho-КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ НАРУШЕНИЙ
JP6752151B2 (ja) 遺伝子サイレンシングにおいて低下したｏｆｆ−ｔａｒｇｅｔ効果を有するｕｎａオリゴマー
IL297129A (en) Carriers for efficient nucleic acid delivery
JP2023506181A5 (https=)
RU2008130857A (ru) Опосредованное phkи ингибирование hif1a для лечения глазного ангиогенеза
RU2007132848A (ru) Опосредуемое rnai ингибирование мишеней глаза
US20190144865A1 (en) Modified tgf-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease
EA031110B1 (ru) Конъюгаты бороновых кислот олигонуклеотидных аналогов
AU747639B2 (en) Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
AR129710A1 (es) Composiciones y métodos para inhibir la expresión de serina proteasa transmembrana 6 (tmprss6)
JP2024538646A5 (https=)
AU2016319072B2 (en) siRNA and their use in methods and compositions for inhibiting the expression of the NRARP gene
JP2024522106A5 (https=)
JP2024526234A5 (https=)
WO2001043731A2 (en) Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
EP4558148A2 (en) Oligonucleotide compositions and methods thereof
US20030083274A1 (en) Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
JP2023514190A5 (https=)
CA3194721A1 (en) Oligomeric compound for dystrophin rescue in dmd patients throughout skipping of exon-51
IL295445A (en) Preparations and methods for silencing vegf-a expression
KR20040014926A (ko) 조합 요법에서의 ｃｒｆ２ 리간드
CA2997648C (en) Sirna and their use in methods and compositions for inhibiting the expression of the nrarp gene